A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres.

Stagni, Venturina; Kaminari, Archontia; Contadini, Claudia; Barilà, Daniela; Sessa, Rosario Luigi; Sideratou, Zili; Vlahopoulos, Spiros A; Tsiourvas, Dimitris

Stagni, Venturina; Kaminari, Archontia; Contadini, Claudia; Barilà, Daniela; Sessa, Rosario Luigi; Sideratou, Zili; Vlahopoulos, Spiros A; Tsiourvas, Dimitris.

Afiliación

Stagni V; Institute of Molecular Biology and Pathology, National Research Council (CNR), 00183 Rome, Italy.
Kaminari A; Laboratory of Cell Signaling, IRCCS, Fondazione Santa Lucia, 00179 Rome, Italy.
Contadini C; Institute of Nanoscience and Nanotechnology, NCSR ''Demokritos", 15310 Aghia Paraskevi, Greece.
Barilà D; Laboratory of Cell Signaling, IRCCS, Fondazione Santa Lucia, 00179 Rome, Italy.
Sessa RL; Department of Biology, University of Tor Vergata, 00133 Rome, Italy.
Sideratou Z; Laboratory of Cell Signaling, IRCCS, Fondazione Santa Lucia, 00179 Rome, Italy.
Vlahopoulos SA; Department of Biology, University of Tor Vergata, 00133 Rome, Italy.
Tsiourvas D; Institute of Molecular Biology and Pathology, National Research Council (CNR), 00183 Rome, Italy.

Cancers (Basel) ; 15(5)2023 Feb 25.

Article en En | MEDLINE | ID: mdl-36900267

Palabras clave

ataxia-telangiectasia mutated kinase; cancer stem cells; triphenylphosphonium cation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google